Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Glioma|Glioma, Malignant|Glioma, Mixed|Glial Cell Tumors|Breast Cancer|Breast Carcinoma|Cancer of Breast|Cancer of the Breast|Breast Tumor|Malignant Tumor of Breast|Advanced Breast Cancer|Advanced Breast Carcinoma|Metastatic Breast Cancer|Metastatic Breast Carcinoma|Prostate Cancer|Prostatic Cancer|Cancer of Prostate|Cancer of the Prostate|Prostate Neoplasm|Castrate Resistant Prostate Cancer|Castration-resistant Prostate Cancer|Castration Resistant Prostatic Neoplasms|Glioblastoma|Recurrent Glioblastoma
Interventions: DRUG: NUV-422
Sponsor: Nuvation Bio Inc.